The immunodominant and neutralization linear epitopes for SARS-CoV-2

SARS-CoV-2 的免疫显性和中和线性表位

阅读:12
作者:Shuai Lu, Xi-Xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-Rui Yang, Guang-Wen Yang, Mei Ji, Cui-Ping Lv, Jian Xue, Er-Hei Dai, Xi-Ming Fu, Dong-Qun Liu, Lun Zhang, Sheng-Jie Hou, Xiao-Lin Yu, Yu-Ling Wang, Hui-Xia Gao, Xue-Han Shi, Chang-Wen Ke, Bi-Xia Ke, Chun-Guo Jiang, Rui-Tian Liu

Abstract

Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are under development, the antigen epitopes on the virus and their immunogenicity are poorly understood. Here, we simulate the 3D structures and predict the B cell epitopes on the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins of SARS-CoV-2 using structure-based approaches and validate epitope immunogenicity by immunizing mice. Almost all 33 predicted epitopes effectively induce antibody production, six of these are immunodominant epitopes in individuals, and 23 are conserved within SARS-CoV-2, SARS-CoV, and bat coronavirus RaTG13. We find that the immunodominant epitopes of individuals with domestic (China) SARS-CoV-2 are different from those of individuals with imported (Europe) SARS-CoV-2, which may be caused by mutations on the S (G614D) and N proteins. Importantly, we find several epitopes on the S protein that elicit neutralizing antibodies against D614 and G614 SARS-CoV-2, which can contribute to vaccine design against coronaviruses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。